Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000137
Filing Date
2025-02-14
Accepted
2025-02-14 16:00:42
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q igc10q123124.htm   iXBRL 10-Q 772542
2 EXHIBIT 31.1 igcex31-1.htm EX-31.1 14777
3 EXHIBIT 31.2 igcex31-2.htm EX-31.2 14945
4 EXHIBIT 32.1 igcex32-1.htm EX-32.1 8594
5 GRAPHIC image_001.jpg GRAPHIC 5364
6 GRAPHIC image_002.jpg GRAPHIC 5012
  Complete submission text file 0001185185-25-000137.txt   4922549

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE igc-20241231.xsd EX-101.SCH 46614
8 XBRL CALCULATION FILE igc-20241231_cal.xml EX-101.CAL 42366
9 XBRL DEFINITION FILE igc-20241231_def.xml EX-101.DEF 207816
10 XBRL LABEL FILE igc-20241231_lab.xml EX-101.LAB 411577
11 XBRL PRESENTATION FILE igc-20241231_pre.xml EX-101.PRE 242424
81 EXTRACTED XBRL INSTANCE DOCUMENT igc10q123124_htm.xml XML 626931
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32830 | Film No.: 25628013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)